OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report
Takayoshi Fuu, Kazuyoshi Iijima, Yukiko Kusama, et al.
Journal of Medical Case Reports (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Takayoshi Fuu, Kazuyoshi Iijima, Yukiko Kusama, et al.
Journal of Medical Case Reports (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Surgery lengthens survival for collecting duct carcinoma: analysis of hospital-based cancer registry data in Japan
Shuya Kandori, Shuhei Suzuki, Kosuke Kojo, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Shuya Kandori, Shuhei Suzuki, Kosuke Kojo, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Collecting Ducts Carcinoma Approach in the New Era of Targeted and Immunotherapy
Dany Nassar, Nahed Damaj, Joseph Kattan
Open Journal of Urology (2025) Vol. 15, Iss. 02, pp. 34-44
Open Access
Dany Nassar, Nahed Damaj, Joseph Kattan
Open Journal of Urology (2025) Vol. 15, Iss. 02, pp. 34-44
Open Access
Sintilimab combined with anlotinib as first-line treatment for advanced sarcomatoid carcinoma of head and neck: a case report and literature review
Lei Wang, Yingyu Huang, Xin Sun
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Lei Wang, Yingyu Huang, Xin Sun
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients
Sebastiano Buti, Francesca Trentini, Pierangela Sepe, et al.
Tumori Journal (2022) Vol. 109, Iss. 4, pp. 418-423
Open Access | Times Cited: 6
Sebastiano Buti, Francesca Trentini, Pierangela Sepe, et al.
Tumori Journal (2022) Vol. 109, Iss. 4, pp. 418-423
Open Access | Times Cited: 6
Surgery lengthens survival for collecting duct carcinoma: Analysis of Hospital-Based Cancer Registry data in Japan
Shuya Kandori, Shuhei Suzuki, Kosuke Kojo, et al.
Research Square (Research Square) (2024)
Open Access
Shuya Kandori, Shuhei Suzuki, Kosuke Kojo, et al.
Research Square (Research Square) (2024)
Open Access
Collecting duct (Bellini duct) renal cell carcinoma: a clinical case and literature review
Н. И. Сорокин, В. Е. Синицын, О А Kharlova, et al.
Urology Herald (2024) Vol. 12, Iss. 2, pp. 108-119
Open Access
Н. И. Сорокин, В. Е. Синицын, О А Kharlova, et al.
Urology Herald (2024) Vol. 12, Iss. 2, pp. 108-119
Open Access
[Analysis of Clinicopathological Characteristics and Factors Affecting the Prognosis of Patients With Resectable Sarcomatoid Carcinoma of the Bladder].
Shiwang Huang, Kaipeng Jia, Chong Shen, et al.
PubMed (2024) Vol. 55, Iss. 5, pp. 1085-1091
Closed Access
Shiwang Huang, Kaipeng Jia, Chong Shen, et al.
PubMed (2024) Vol. 55, Iss. 5, pp. 1085-1091
Closed Access
Tumeurs de Bellini et carcinomes médullaires rénaux à l’ère des nouvelles thérapies
Zoé Guillaume, Yves Allory, Édouard Auclin, et al.
Bulletin du Cancer (2023) Vol. 110, Iss. 4, pp. 450-462
Open Access | Times Cited: 1
Zoé Guillaume, Yves Allory, Édouard Auclin, et al.
Bulletin du Cancer (2023) Vol. 110, Iss. 4, pp. 450-462
Open Access | Times Cited: 1
